Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-clinical Participants”

180 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 180 results

Testing effectiveness (Phase 2)Looking for participantsNCT06800963
What this trial is testing

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

Who this might be right for
NMIBC
ImmunityBio, Inc. 40
Large-scale testing (Phase 3)Active Not RecruitingNCT04246177
What this trial is testing

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 480
Large-scale testing (Phase 3)Active Not RecruitingNCT03815643
What this trial is testing

Avelumab Program Rollover Study

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 205
Testing effectiveness (Phase 2)Study completedNCT03717155
What this trial is testing

Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With NSCLC

Who this might be right for
Squamous Non-Small Cell Lung Cancer
Merck KGaA, Darmstadt, Germany 43
Large-scale testing (Phase 3)Active Not RecruitingNCT03711032
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

Who this might be right for
High-risk Non-muscle Invasive Bladder Cancer
Merck Sharp & Dohme LLC 1,397
Testing effectiveness (Phase 2)Study completedNCT02629822
What this trial is testing

Safety and Efficacy of Doravirine, Tenofovir, Lamivudine (MK-1439A) in Participants Infected With Treatment-Naïve Human Immunodeficiency Virus (HIV) -1 With Transmitted Resistance (MK-1439A-030)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 10
Early research (Phase 1)Study completedNCT04364464
What this trial is testing

Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight

Who this might be right for
Clinical Pharmacology
Bayer 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03162536
What this trial is testing

Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

Who this might be right for
Lymphoma, B-CellSmall Lymphocytic LymphomaChronic Lymphocytic Leukemia+6 more
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 190
Early research (Phase 1)Active Not RecruitingNCT06253520
What this trial is testing

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

Who this might be right for
Metastatic Solid CancersColorectal CancerBreast Cancer+4 more
National Cancer Institute (NCI) 210
Testing effectiveness (Phase 2)Study completedNCT03936426
What this trial is testing

Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATE™

Who this might be right for
Meningioma
Clarity Pharmaceuticals Ltd 5
Early research (Phase 1)Study completedNCT04317066
What this trial is testing

Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-A33/KEYNOTE-A33)

Who this might be right for
Lymphoma, B-Cell
Merck Sharp & Dohme LLC 7
Large-scale testing (Phase 3)Active Not RecruitingNCT06698042
What this trial is testing

A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)

Who this might be right for
Lung CancerNon-Small Cell Lung Cancer
Merck Sharp & Dohme LLC 67
Not applicableUnknownNCT05798598
What this trial is testing

Evaluation of Competencies in Scientific Writing and Attendees' Satisfaction After Two Different Types of Training Courses: SCRIU-B Study

Who this might be right for
Scientific Writing Training Course
Dr. Antoni Esteve Foundation 270
Large-scale testing (Phase 3)Study completedNCT02830919
What this trial is testing

Clinical Study of Non-inferiority With Participants Diagnosed With Primary Knee OA (GLACIAL)

Who this might be right for
Osteoarthritis of Knee
Eurofarma Laboratorios S.A. 627
Not applicableEnded earlyNCT02616328
What this trial is testing

The Efficacy and Safety of Tocilizumab for Confirmed Rheumatoid Arthritis (RA) Participants in Clinical Practice

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 8
Large-scale testing (Phase 3)Looking for participantsNCT05645107
What this trial is testing

Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

Who this might be right for
HypogammaglobulinemiaBacterial InfectionsB-cell Chronic Lymphocytic Leukemia+2 more
Grifols Therapeutics LLC 386
Not applicableEnrolling By InvitationNCT06802029
What this trial is testing

PUER ("Previously Unrecognized Emerging Risks") Life Clinical Study (PUER) in Ages 6 Through 18

Who this might be right for
Aging
Puer Research, LLC 10,000
Post-approval studies (Phase 4)Study completedNCT02142205
What this trial is testing

Safety and Efficacy of Natalizumab (BG00002, Tysabri®) in Russian Participants With Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 100
Testing effectiveness (Phase 2)Looking for participantsNCT06833073
What this trial is testing

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Who this might be right for
Urinary Bladder NeoplasmsNon-Muscle Invasive Bladder NeoplasmsCarcinoma in Situ
Merck Sharp & Dohme LLC 308
Not applicableStudy completedNCT01672957
What this trial is testing

An Observational Study on Renal Function in Kidney Transplant Participants on Immunosuppressive Therapy Containing Mycophenolate Mofetil

Who this might be right for
Kidney Transplantation
Hoffmann-La Roche 128
Load More Results